2024-09-01 2025-08-31 false Capium Accounts Production 1.1 07734974 2024-09-01 2025-08-31 07734974 bus:AbridgedAccounts 2024-09-01 2025-08-31 07734974 bus:FRS102 2024-09-01 2025-08-31 07734974 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 07734974 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 07734974 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 07734974 2024-09-01 2025-08-31 07734974 2025-08-31 07734974 bus:RegisteredOffice 2024-09-01 2025-08-31 07734974 core:WithinOneYear 2025-08-31 07734974 core:AfterOneYear 2025-08-31 07734974 1 2024-09-01 2025-08-31 07734974 bus:Director1 2024-09-01 2025-08-31 07734974 bus:Director1 2025-08-31 07734974 bus:Director1 2023-09-01 2024-08-31 07734974 2023-09-01 07734974 bus:CompanySecretary1 2024-09-01 2025-08-31 07734974 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 07734974 2023-09-01 2024-08-31 07734974 2024-08-31 07734974 core:WithinOneYear 2024-08-31 07734974 core:AfterOneYear 2024-08-31 07734974 bus:EntityAccountantsOrAuditors 2023-09-01 2024-08-31 07734974 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 07734974 bus:OrdinaryShareClass1 2025-08-31 07734974 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 07734974 bus:OrdinaryShareClass1 2024-08-31 07734974 core:LandBuildings 2024-09-01 2025-08-31 07734974 core:LandBuildings 2025-08-31 07734974 core:LandBuildings 2024-08-31 07734974 core:PlantMachinery 2024-09-01 2025-08-31 07734974 core:PlantMachinery 2025-08-31 07734974 core:PlantMachinery 2024-08-31 07734974 core:MotorCars 2024-09-01 2025-08-31 07734974 core:MotorCars 2025-08-31 07734974 core:MotorCars 2024-08-31 07734974 core:FurnitureFittings 2024-09-01 2025-08-31 07734974 core:FurnitureFittings 2025-08-31 07734974 core:FurnitureFittings 2024-08-31 07734974 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-08-31 07734974 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-08-31 07734974 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 07734974 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 07734974 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 07734974 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 07734974 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 07734974 core:Non-currentFinancialInstruments 2025-08-31 07734974 core:Non-currentFinancialInstruments 2024-08-31 07734974 core:ShareCapital 2025-08-31 07734974 core:ShareCapital 2024-08-31 07734974 core:RetainedEarningsAccumulatedLosses 2025-08-31 07734974 core:RetainedEarningsAccumulatedLosses 2024-08-31 07734974 dpl:Item1 2024-09-01 07734974 dpl:Item1 2025-08-31 07734974 dpl:Item1 2023-09-01 07734974 dpl:Item1 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07734974
England & Northern Ireland

 

 

 

PHARMALINC LTD



Abridged Accounts
 


Period of accounts

Start date: 01 September 2024

End date: 31 August 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 53,980    42,322 
53,980    42,322 
Current assets      
Stocks 16,733    19,364 
Debtors 640,613    599,912 
Cash at bank and in hand 392,720    388,187 
1,050,066    1,007,463 
Creditors: amount falling due within one year (369,536)   (378,203)
Net current assets 680,530    629,260 
 
Total assets less current liabilities 734,510    671,582 
Provisions for liabilities (169)   (152)
Net assets 734,341    671,430 
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 734,340    671,429 
Shareholders' funds 734,341    671,430 
 


For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 26 May 2026 and were signed by:


-------------------------------
Mr Suhel Y Patel
Director
1
General Information
Pharmalinc Ltd is a private company, limited by shares, registered in England & Northern Ireland, registration number 07734974, registration address 40 Melbourne Road, Ilford, Essex, IG1 4LG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 6 Years Straight Line
Motor Vehicles 4 Years Straight Line
Fixtures and Fittings 5 Years Straight Line
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 11 (2024 : 10).
3.

Tangible fixed assets

Cost or valuation Land and Buildings   Plant and Machinery   Motor Vehicles   Fixtures and Fittings   Total
  £   £   £   £   £
At 01 September 2024   45,000    41,705    28,022    114,727 
Additions   11,000    31,360      42,360 
Disposals        
At 31 August 2025   56,000    73,065    28,022    157,087 
Depreciation
At 01 September 2024   22,500    25,173    24,732    72,405 
Charge for year 10,714      16,698    3,290    30,702 
On disposals        
At 31 August 2025 10,714    22,500    41,871    28,022    103,107 
Net book values
Closing balance as at 31 August 2025 (10,714)   33,500    31,194      53,980 
Opening balance as at 01 September 2024   22,500    16,532    3,290    42,322 


4.

Share Capital

Authorised
1 Class A share of £1.00 each
Allotted, called up and fully paid
2025
£
  2024
£
1 Class A share of £1.00 each  
 

2